Autoimmunity

Microbiome in Sjögren’s syndrome: here we are
Taco A van der Meulen, Arjan Vissink, Hendrika Bootsma, Fred K L Spijkervet, Frans G M Kroese

Annals of the Rheumatic Diseases Jul 2020, annrheumdis-2020-218213; DOI: 10.1136/annrheumdis-2020-218213
Response to: ‘Microbiome in Sjögren’s syndrome: here we are’ by van der Meulen et al
Julia Manasson, Rebecca B Blank, Jose U Scher

Annals of the Rheumatic Diseases Jul 2020, annrheumdis-2020-218327; DOI: 10.1136/annrheumdis-2020-218327
Clinical features of rheumatic patients infected with COVID-19 in Wuhan, China
Cong Ye, Shaozhe Cai, Guifen Shen, Hanxiong Guan, Liling Zhou, Yangyang Hu, Wei Tu, Yu Chen, Yikai Yu, Xuefen Wu, Yuxue Chen, Jixin Zhong, Lingli Dong

Annals of the Rheumatic Diseases Aug 2020, 79 (8) 1007-1013; DOI: 10.1136/annrheumdis-2020-217627
Mycophenolate mofetil: a step forward in the induction treatment of ANCA-associated vasculitis? Comment on the article by Jones et al
Frédéric Alain Vandergheynst, Christophe Lelubre

Annals of the Rheumatic Diseases Aug 2020, 79 (8) e100; DOI: 10.1136/annrheumdis-2019-215647
Decision-making value of nuclear dense fine speckled pattern in systemic autoimmune rheumatic disease: trick or treat?
Chuiwen Deng, Xiaohui Qu, Shaoyun Cheng, Xiaofeng Zeng, Yongzhe Li, Yunyun Fei

Annals of the Rheumatic Diseases Aug 2020, 79 (8) e92; DOI: 10.1136/annrheumdis-2019-215587
Eosinophilic granulomatosis with polyangiitis can manifest lacrimal and salivary glands swelling by granulomatous inflammation: a potential mimicker of IgG4-related disease
Mitsuhiro Akiyama, Yuko Kaneko, Tsutomu Takeuchi

Annals of the Rheumatic Diseases Jun 2020, annrheumdis-2020-218124; DOI: 10.1136/annrheumdis-2020-218124
Clinical features and outcomes of COVID-19 in patients with rheumatic diseases treated with biological and synthetic targeted therapies
Carlos Sanchez-Piedra, Cesar Diaz-Torne, Javier Manero, José M Pego-Reigosa, Íñigo Rúa-Figueroa, Miguel A Gonzalez-Gay, Juan Gomez-Reino, Jose M Alvaro-Gracia

Annals of the Rheumatic Diseases Jul 2020, 79 (7) 988-990; DOI: 10.1136/annrheumdis-2020-217948
Antisynthetase antibodies in clinical laboratories: the importance of clinical correlation and indirect immunofluorescence. Response to: Comment on: ‘Idiopathic inflammatory myopathies and antisynthetase syndrome: contribution of antisynthetase antibodies to improve current classification criteria’ by Greco et al’ by Knitza et al
Martin Greco, Mª Jesus García de Yébenes, Inmaculada Alarcón, Anahy María Brandy-García, Íñigo Rúa-Figueroa, Estibaliz Loza, Loreto Carmona

Annals of the Rheumatic Diseases Jul 2020, 79 (7) e87; DOI: 10.1136/annrheumdis-2019-215766
Preliminary recommendations of the German Society of Rheumatology (DGRh eV) for the management of patients with inflammatory rheumatic diseases during the SARS-CoV-2/COVID-19 pandemic
Hendrik Schulze-Koops, Christof Specker, Christof Iking-Konert, Julia Holle, Frank Moosig, Klaus Krueger

Annals of the Rheumatic Diseases Jun 2020, 79 (6) 840-842; DOI: 10.1136/annrheumdis-2020-217628
Antinuclear antibodies mitotic patterns and their clinical associations
Juan F Betancur, José A Gómez-Puerta

Annals of the Rheumatic Diseases Jun 2020, 79 (6) e63; DOI: 10.1136/annrheumdis-2019-215428

Main menu

Autoimmunity

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Autoimmunity

Pages